CSF to serum ratios for anti-LINGO-1 mAb BIIB033 measured 2 weeks post dose are 0.032–0.079% in healthy volunteers and 0.03–0.13% in individuals with multiple sclerosis [17]. The gene discussed is LINGO1; the disease is multiple sclerosis.